‘Whole-Body’ Perspectives of Schizophrenia and Related Psychotic Illness: miRNA-143 as an Exemplary Molecule Implicated across Multi-System Dysfunctions
Biomolecules · 20.09.2024 · 14 (9) · 1185
DOI: 10.3390/biom14091185 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 20.09.2024. Verfasst von John L Waddington und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland. Hauptthemen laut MEDLINE: Schizophrenia, MicroRNAs. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou International Academician Workstation Program, National Key Research and Development Program of China, Priority Academic Program Development of the Jiangsu Higher Education Institutes.
Abstract (Originalsprache)
A wide array of biological abnormalities in psychotic illness appear to reflect non-cerebral involvement. This review first outlines the evidence for such a whole-body concept of schizophrenia pathobiology, focusing particularly on cardiovascular disease, metabolic syndrome and diabetes, immunity and inflammation, cancer, and the gut–brain axis. It then considers the roles of miRNAs in general and of miRNA-143 in particular as they relate to the epidemiology, pathobiology, and treatment of schizophrenia. This is followed by notable evidence that miRNA-143 is also implicated in each of these domains of cardiovascular disease, metabolic syndrome and diabetes, immunity and inflammation, cancer, and the gut–brain axis. Thus, miRNA-143 is an exemplar of what may be a class of molecules that play a role across the multiple domains of bodily dysfunction that appear to characterize a whole-body perspective of illness in schizophrenia. Importantly, the existence of such an exemplary molecule across these multiple domains implies a coordinated rather than stochastic basis. One candidate process would be a pleiotropic effect of genetic risk for schizophrenia across the whole body.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.
- Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psychiatric-Disorders, Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
Förderung
- Suzhou International Academician Workstation Program
- National Key Research and Development Program of China
- Priority Academic Program Development of the Jiangsu Higher Education Institutes
Zitieren
APA
Waddington, J. L., Wang, X., & Zhen, X. (2024). ‘Whole-Body’ Perspectives of Schizophrenia and Related Psychotic Illness: miRNA-143 as an Exemplary Molecule Implicated across Multi-System Dysfunctions. Biomolecules, 14(9), 1185. https://doi.org/10.3390/biom14091185
Vancouver
Waddington JL, Wang X, Zhen X. ‘Whole-Body’ Perspectives of Schizophrenia and Related Psychotic Illness: miRNA-143 as an Exemplary Molecule Implicated across Multi-System Dysfunctions. Biomolecules. 2024;14(9):1185. doi:10.3390/biom14091185
BibTeX
@article{Waddington2024,
author = {Waddington, John L and Wang, Xiaoyu and Zhen, Xuechu},
title = {‘Whole-Body’ Perspectives of Schizophrenia and Related Psychotic Illness: miRNA-143 as an Exemplary Molecule Implicated across Multi-System Dysfunctions},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {9},
pages = {1185},
doi = {10.3390/biom14091185}
}
EUVIMED